Patents by Inventor Michael Marks

Michael Marks has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Method of preparing a hair treatment formulation comprising nanoparticles in solution and method of hair treatment utilizing a treatment formulation comprising nanoparticles in solution
    Patent number: 9682020
    Abstract: A hair treatment formulation comprises a plurality of composite nanoparticles in solution. The composite nanoparticles of at least one alternative embodiment are specifically prepared having a first inner layer comprising one or more acidic component, a second inner layer comprising one or more thiolate, and an outer layer comprising peptides formed one or more amino acids of hydrolyzed keratin protein. At least one treatment component is embedded in at least one of the first inner layer, second inner layer, or the outer layer. Alternative methods of preparing a hair treatment formulation comprising composite nanoparticles is disclosed along with alternative methods of use of the alternative hair treatment formulations comprising a plurality of composite nanoparticles.
    Type: Grant
    Filed: July 9, 2015
    Date of Patent: June 20, 2017
    Assignee: KERATIN HOLDINGS LLC
    Inventor: Michael Mark Anthony
  • COMBINATION THERAPY
    Publication number: 20170151249
    Abstract: The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor.
    Type: Application
    Filed: February 9, 2017
    Publication date: June 1, 2017
    Inventors: Thomas KLEIN, Rolf GREMPLER, Michael MARK
  • CONNECTORS FOR LANDSCAPE LIGHTING SYSTEMS
    Publication number: 20170133770
    Abstract: A connector includes a cable tray configured to receive and retain a cable in a stable position and couple with a top cap configured to create an electrical connection with the cable as the top cap is manipulated in a predetermined manner while coupled with the cable tray. An upper surface of the cable tray is configured to receive the cable. The cable tray also includes a finger extending beyond the first end for some distance longitudinally. The finger includes a protrusion that protrudes to some extent in a transverse direction so that a cable-accommodating gap is defined between the protrusion and the first end. The protrusion is configured to bear against the cable and retain the cable in the stable position when the cable is inserted between the protrusion and the first end (before, during and/or after an electrical connection is established).
    Type: Application
    Filed: January 13, 2017
    Publication date: May 11, 2017
    Inventors: Jean Tuck McGregor, James Michael Broughman, Allen R. Nelson, Darren Michael Mark, Laura Winfield Alexander
  • Charge conservation in pixels
    Patent number: 9648263
    Abstract: Representative implementations of devices and techniques provide conservation of charge in a pixel. Charge in the pixel may be alternately stored in a first gate capacitance of the pixel and a second gate capacitance of the pixel. Transferring the charge between the gate capacitances conserves some or all of the charge, and reduces input power used to charge the gate capacitances.
    Type: Grant
    Filed: November 28, 2012
    Date of Patent: May 9, 2017
    Assignee: Infineon Technologies AG
    Inventors: Markus Dielacher, Martin Flatscher, Josef Prainsack, Franz Darrer, Michael Mark
  • Integrated reference pixel
    Patent number: 9635351
    Abstract: Representative implementations of devices and techniques provide dynamic calibration for imaging devices and systems. A reference pixel is arranged to receive an electrical reference signal and to output a calibration signal. The reference signal may be based on imaging illumination.
    Type: Grant
    Filed: November 20, 2013
    Date of Patent: April 25, 2017
    Assignee: Infineon Technologies AG
    Inventors: Markus Dielacher, Martin Flatscher, Michael Mark, Josef Prainsack
  • USES OF DPP IV INHIBITORS
    Publication number: 20170087160
    Abstract: The specification describes the use of selected DPP IV inhibitors for the treatment of physiological functional disorders and for reducing the risk of the occurrence of such functional disorders in at-risk patient groups. In addition, the use of the above-mentioned DPP IV inhibitors in conjunction with other active substances is described, by means of which improved treatment outcomes can be achieved. These applications may be used to prepare corresponding medicaments.
    Type: Application
    Filed: December 8, 2016
    Publication date: March 30, 2017
    Inventors: Klaus DUGI, Frank HIMMELSBACH, Michael MARK
  • Combination therapy
    Patent number: 9603851
    Abstract: The present invention relates to methods for treating and/or preventing metabolic diseases comprising the combined administration of a GLP-1 receptor agonist and a DPP-4 inhibitor.
    Type: Grant
    Filed: October 2, 2015
    Date of Patent: March 28, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Klein, Rolf Grempler, Michael Mark
  • 8-[3-AMINO-PIPERIDIN-1-YL]-XANTHINES, THE PREPARATION THEREOF AND THEIR USE AS PHARMACEUTICAL COMPOSITIONS
    Publication number: 20170081329
    Abstract: The present invention relates to substituted xanthines of general formula wherein R1 to R3 are as defined herein, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    Type: Application
    Filed: December 1, 2016
    Publication date: March 23, 2017
    Inventors: Frank HIMMELSBACH, Elke LANGKOPF, Matthias ECKHARDT, Michael MARK, Roland MAIER, Ralf LOTZ, Mohammad TADAYYON
  • USE OF A DPP-4 INHIBITOR IN PODOCYTES RELATED DISORDERS AND/OR NEPHROTIC SYNDROME
    Publication number: 20170065595
    Abstract: The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of podocytes related disorders and/or nephrotic syndrome.
    Type: Application
    Filed: November 17, 2016
    Publication date: March 9, 2017
    Inventors: Thomas KLEIN, Maximilian von EYNATTEN, Berthold HOCHER, Michael MARK, Yuliya SHARKOVSKA
  • Connector having a cap with a brace to prevent decoupling of the cap from an engagement member
    Patent number: 9583843
    Abstract: A connector includes a cable tray configured to receive and retain a cable in a stable position and couple with a top cap configured to create an electrical connection with the cable as the top cap is manipulated in a predetermined manner while coupled with the cable tray. An upper surface of the cable tray is configured to receive the cable. The cable tray also includes a finger extending beyond the first end for some distance longitudinally. The finger includes a protrusion that protrudes to some extent in a transverse direction so that a cable-accommodating gap is defined between the protrusion and the first end. The protrusion is configured to bear against the cable and retain the cable in the stable position when the cable is inserted between the protrusion and the first end (before, during and/or after an electrical connection is established).
    Type: Grant
    Filed: September 30, 2014
    Date of Patent: February 28, 2017
    Assignee: LOWE'S COMPANIES, INC.
    Inventors: Jean Tuck McGregor, James Michael Broughman, Allen R. Nelson, Darren Michael Mark, Laura Winfield Alexander, Donald Collins Meves
  • IMAGING APPARATUS AND IMAGING METHOD FOR CAPTURING IMAGING DATA VIA A PIXEL ARRAY
    Publication number: 20170034464
    Abstract: The present disclosure relates to an imaging apparatus. The imaging apparatus comprises a pixel array. The pixel array comprises a first pixel comprising a first radiation-sensitive region and at least one associated charge storage region for collecting electrical charges from the first radiation-sensitive region. The pixel array also comprises a second pixel comprising a second radiation-sensitive region and at least one associated charge storage region for collecting electrical charges from the second radiation-sensitive region. Furthermore, the imaging apparatus comprises control circuitry configured to generate a common compensation signal being common to the first and second pixels. The common compensation signal mitigates a saturation of the respective charge storage regions of the first and second pixels.
    Type: Application
    Filed: June 29, 2016
    Publication date: February 2, 2017
    Inventors: Markus DIELACHER, Martin FLATSCHER, Stefan GANSINGER, Michael MARK, Josef PRAINSACK, Hartwig UNTERASSINGER
  • 8-[3-amino-piperidin-1-yl]-xanthines, the preparation thereof and thier use as pharmaceutical compositions
    Patent number: 9556175
    Abstract: The present invention relates to substituted xanthines of general formula wherein R1 to R3 are as defined herein, the tautomers, the stereoisomers, the mixtures, the prodrugs thereof and the salts thereof which have valuable pharmacological properties, particularly an inhibiting effect on the activity of the enzyme dipeptidylpeptidase-IV (DPP-IV).
    Type: Grant
    Filed: March 15, 2016
    Date of Patent: January 31, 2017
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Frank Himmelsbach, Elke Langkopf, Matthias Eckhardt, Michael Mark, Roland Maier, Ralf Lotz, Mohammad Tadayyon
  • PHARMACEUTICAL COMPOSITION, METHODS FOR TREATING AND USES THEREOF
    Publication number: 20170020907
    Abstract: The invention relates to the treatment or prevention of one or more conditions selected from type 1 diabetes mellitus, type 2 diabetes mellitus, impaired glucose tolerance and hyperglycemia using a SGLT-2 inhibitor. In addition the present invention relates to methods for preventing or treating of metabolic disorders and related conditions.
    Type: Application
    Filed: October 5, 2016
    Publication date: January 26, 2017
    Inventors: Peter EICKELMANN, Michael MARK, Leo John SEMAN, Leo THOMAS, Uli Christian BROEDL, Rolf GREMPLER
  • Use of a DPP-4 inhibitor in podocytes related disorders and/or nephrotic syndrome
    Patent number: 9526730
    Abstract: The present invention relates to methods for treating and/or preventing podocytes related disorders and/or nephrotic syndrome comprising the administration of an effective amount of a certain DPP-4 inhibitor, as well as to the use of a certain DPP-4 inhibitor for treating and/or preventing a metabolic disease in a patient with or at risk of podocytes related disorders and/or nephrotic syndrome.
    Type: Grant
    Filed: October 30, 2015
    Date of Patent: December 27, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Thomas Klein, Maximilian von Eynatten, Berthold Hocher, Michael Mark, Yuliya Sharkovska
  • TREATMENT OF GENOTYPED DIABETIC PATIENTS WITH DPP-IV INHIBITORS SUCH AS LINAGLIPTIN
    Publication number: 20160354380
    Abstract: The present invention relates to methods for preventing or treating of metabolic disorders and related conditions, such as in certain patient groups.
    Type: Application
    Filed: August 12, 2016
    Publication date: December 8, 2016
    Inventors: Klaus DUGI, Eva Ulrike GRAEFE-MODY, Michael MARK, Hans-Juergen WOERLE, Heike ZIMDAHL-GELLING
  • 1-[(3-CYANO-PYRIDIN-2-YL)METHYL]-3-METHYL-7-(2-BUTYN-1-YL)-8-[3-(R)-AMINO-PIPERIDIN-1-YL]-XANTHINE FOR THE TREATMENT OF A METABOLIC DISORDER OF A PREDOMINANTLY CARNIVOROUS NON-HUMAN ANIMAL
    Publication number: 20160346288
    Abstract: A method of treating a metabolic disorder or metabolic disease includes administering a pharmaceutically effective dose of 1-[(3-cyano-pyridin-2-yl)methyl]-3-methyl-7-(2-butyn-1-yl)-8-[3-(R)-amino-piperidin-1-yl]-xanthine, or a pharmaceutically acceptable salt thereof, to a predominantly carnivorous non-human animal in need thereof such that the severity of one or more clinical symptoms of the metabolic disorder or metabolic disease is reduced.
    Type: Application
    Filed: August 13, 2016
    Publication date: December 1, 2016
    Inventors: Frerich DE VRIES, Dirk HOERSTERMANN, Ingo LANG, Michael MARK, Randolph SEIDLER, Leo THOMAS
  • Photocatalytic teeth whitening
    Patent number: 9492257
    Abstract: The present disclosure relates to devices, methods and kits for accelerating the rate of whitening of teeth using an oxidizing agent, a photocatalytic agent, and a portable lightsource.
    Type: Grant
    Filed: September 3, 2014
    Date of Patent: November 15, 2016
    Assignee: Jasibo, LLC
    Inventors: Jennifer Jablow, Michael Mark Muehlemann
  • SYSTEMS AND METHODS FOR TIME OF FLIGHT MEASUREMENT USING A SINGLE EXPOSURE
    Publication number: 20160327638
    Abstract: A sensor array arrangement for a time of flight measurement system is disclosed. The arrangement includes a plurality of pixels and circuitry. The plurality of pixels are configured such that a first plurality of pixels receive a first reference signal and a second plurality of pixels receive a second reference signal. The first and second reference signals are phase shifted with respect to each other. The circuitry calculates depth information by combining information from first and second pixel sensor signals. The first pixel sensor signal is based on the first reference signal. The second pixel sensor signal is based on the second reference signal.
    Type: Application
    Filed: May 4, 2015
    Publication date: November 10, 2016
    Inventors: Markus Dielacher, Josef Prainsack, Martin Flatscher, Michael Mark, Hartwig Unterassinger
  • Treatment of genotyped diabetic patients with DPP-IV inhibitors such as linagliptin
    Patent number: 9457029
    Abstract: The present invention relates to methods for preventing or treating of metabolic disorders and related conditions, such as in certain patient groups.
    Type: Grant
    Filed: November 26, 2010
    Date of Patent: October 4, 2016
    Assignee: Boehringer Ingelheim International GmbH
    Inventors: Klaus Dugi, Eva Ulrike Graefe-Mody, Michael Mark, Hans-Juergen Woerle, Heike Zimdahl-Gelling
  • Handle for a vehicle
    Patent number: D772682
    Type: Grant
    Filed: October 23, 2014
    Date of Patent: November 29, 2016
    Assignee: Caterpillar Inc.
    Inventors: Jason Edward Stibs, Michael Eugene Lee, Michael Mark Conrad, Michael Scott Hemry, Gregory James Parsons